News

How AI Sovereignty Will Reshape Global Enterprise AI Strategy
Understanding this shift requires examining three interconnected factors that forward-thinking enterprises are incorporating ...
Claudin 18.2-Directed Oncology Therapeutics--A Fast-Growing Market with Blockbuster Potential | DelveInsight
DelveInsight's Claudin 18.2 Directed Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report ...
Computer Weekly6d
IBM chief confident AI isn’t eroding other parts of the business
Chairman, president and CEO Arvind Krishna talks of growth and margin expansion as Big Blue expects artificial intelligence to deliver internal savings of $4.5bn this year.
DelveInsight Business Research, LLP: Claudin 18.2-Directed Oncology Therapeutics--A Fast-Growing Market with Blockbuster Potential | DelveInsight
Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering, combination strategies ...